Observational Studies on Asbestos

PubMed, the National Library of Medicine's index of medical journals, labels every article with its publication type. 72 studies in our library are labeled as studies that observe people without assigning a treatment. The labels are NLM's, not ours. Each entry links to the study on PubMed and to its journal's page in our library, where you can read the abstract.

2020s

• Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS study. F. Khan, I. Stewart, L. Howard, et al. BMJ Open Respiratory Research 2026;13(1). PubMed · Publisher · Free full text
• Interaction between ENPP1 and homologous recombination deficiency defines distinct pan-cancer signatures: A retrospective observational study. Y.M. Kim, S.H. Lee, W. Na, et al. Medicine 2026;105(1):e47164. PubMed · Publisher · Free full text
• Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. K. Yerigeri, M. Sengupta, J. Zhang, et al. Clinical Lung Cancer 2026;27(5):77-86.e1. PubMed · Publisher · Free full text
• Thoracolithiasis: a rare and frequently underrecognized entity - a retrospective single-center study and narrative literature review. C. İşevi, M.G. Pirzirenli, B.C. Öten, et al. BMC Surgery 2026;26(1). Review PubMed · Publisher · Free full text
• Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study. C.R. Mayland, M. Collinson, S.H. Ahmedzai, et al. BMC Palliative Care 2026;25(1). PubMed · Publisher · Free full text
• Asbestos Burden in Lungs of Subjects Deceased From Mesothelioma Who Lived in Proximity to an Asbestos Factory: A Topographic Post-Mortem SEM-EDS Study. S.D. Visonà, M. Untalan, B. Bertoglio, et al. American Journal of Industrial Medicine 2025;68(2):112-121. PubMed · Publisher · Free full text
• CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study. N. Wu, C. Xue, S. Yu, et al. Scientific Reports 2025;15(1):6819. PubMed · Publisher · Free full text
• Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic Scores. B. Prassas, Z. Shi, H. Tran, et al. Cancer Medicine 2025;14(11):e70990. PubMed · Publisher · Free full text
• Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease. X. Wu, F.V. Hernandez, H. Wang, et al. Journal of Thoracic Oncology 2025;20(11):1699-1715. PubMed · Publisher · Free full text
• Quality of life in patients with PICC diagnosed with mesothelioma: Results of a multicenter epidemiological survey (LifePICC). T. Bolgeo, R. Di Matteo, S. Crivellari, et al. The Journal of Vascular Access 2025;26(1):217-227. PubMed · Publisher
• Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry. H. Ersöz, M. Torres-Durán, A.M. Turner, et al. Archivos de Bronconeumología 2025;61(1):22-30. In English, Spanish. PubMed · Publisher
• The application value of HRCT quantitative analysis in early pneumoconiosis and concomitant diseases. X. Hu, X.D. Liu, T. Gao, et al. Medicine 2025;104(18):e42374. PubMed · Publisher · Free full text
• The Role of Breath Analysis in the Non-Invasive Early Diagnosis of Malignant Pleural Mesothelioma (MPM) and the Management of At-Risk Individuals. M. Nisi, A. Di Gilio, J. Palmisani, et al. Molecules 2025;30(19). PubMed · Publisher · Free full text
• Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study. S. Yaşar, F. Yılmaz, G. Utkan, et al. Annals of Surgical Oncology 2024;31(9):6228-6236. PubMed · Publisher · Free full text
• Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma. R. Okita, T. Senoo, Y. Mimura-Kimura, et al. Scientific Reports 2024;14(1):15947. PubMed · Publisher · Free full text
• Decade-long insights: tracking asbestos-related health impacts among formerly exposed workers in Palermo, Italy. C. Costantino, C. Ledda, M. Riccò, et al. Annali di Igiene 2024;36(5):525-536. PubMed · Publisher
• Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study. A. Gault, L. Hogarth, K.C. Williams, et al. BMC Cancer 2024;24(1):733. PubMed · Publisher · Free full text
• Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases. A. Mervic, K. Goricar, T. Blagus, et al. Radiology and Oncology 2024;58(1):87-98. PubMed · Publisher · Free full text
• Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study. Y. Takeda, G. Naka, Y. Katsuya, et al. BMC Cancer 2023;23(1):800. PubMed · Publisher · Free full text
• Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma. A. Alnajar, S.A. Kareff, S.S. Razi, et al. JAMA Network Open 2023;6(3):e234261. PubMed · Publisher · Free full text
• Intraoperative nociception and postoperative inflammation associated with the suppression of major complications due to thoracic epidural block after pleurectomy/decortication for malignant pleural mesothelioma under general anesthesia: A retrospective observational study. Y. Hamanaka, W. Ueda, K. Taki, et al. Medicine 2023;102(35):e34832. PubMed · Publisher · Free full text
• Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance. K. Ferguson, M. Neilson, R. Mercer, et al. BMJ Open 2023;13(8):e067780. PubMed · Publisher · Free full text
• Changes in body composition in patients with malignant pleural mesothelioma and the relationship with activity levels and dietary intake. E. Jeffery, Y.C.G. Lee, R.U. Newton, et al. European Journal of Clinical Nutrition 2022;76(7):979-986. PubMed · Publisher · Free full text
• High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study. R. Ma, S. Li, Y. Wang, et al. BMC Pulmonary Medicine 2022;22(1):207. PubMed · Publisher · Free full text
• Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma. D. De Fonseka, D.T. Arnold, A.J. Morley, et al. BMC Pulmonary Medicine 2022;22(1):173. PubMed · Publisher · Free full text
• Toxic Occupational Exposures and Membranous Nephropathy. M. Cremoni, S. Agbekodo, M. Teisseyre, et al. Clinical Journal of the American Society of Nephrology 2022;17(11):1609-1619. PubMed · Publisher · Free full text
• Understanding clinical decision-making in mesothelioma care: a mixed methods study. C. Henshall, P. Dawson, N. Rahman, et al. BMJ Open Respiratory Research 2022;9(1). PubMed · Publisher · Free full text
• Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma. T. Hod, K.J. Freedberg, S.S. Motwani, et al. The Journal of Thoracic and Cardiovascular Surgery 2021;161(4):1510-1518. PubMed · Publisher
• Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study. N. Benzerdjeb, P. Dartigues, V. Kepenekian, et al. Virchows Archiv 2021;479(5):927-936. PubMed · Publisher
• Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study. A. Patel, L. Roshkovan, S. McNulty, et al. Clinical Lung Cancer 2021;22(3):210-217.e1. PubMed · Publisher
• Diaphragm reconstruction by GORE DUALMESH in patients undergoing resection for thoracic malignancies. A. Sano, Y. Azuma, T. Sakai, et al. Journal of Cardiothoracic Surgery 2021;16(1):65. PubMed · Publisher · Free full text
• Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study. B. Chollet, J. Guinde, S. Laroumagne, et al. Thoracic Cancer 2021;12(11):1752-1756. PubMed · Publisher · Free full text
• Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis. S. Abd Own, J. Höijer, G. Hillerdahl, et al. Diagnostic Cytopathology 2021;49(5):606-614. PubMed · Publisher
• Integrated genomics point to immune vulnerabilities in pleural mesothelioma. A. Nastase, A. Mandal, S.K. Lu, et al. Scientific Reports 2021;11(1):19138. PubMed · Publisher · Free full text
• Malignant pleural mesothelioma: clinical experience and prognostic value of derived neutrophil-to-lymphocyte ratio and PD-L1 expression. L. Gutierrez-Sainz, P. Cruz, S. Martinez-Recio, et al. Clinical & Translational Oncology 2021;23(10):2030-2035. PubMed · Publisher
• Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases. S. Tsim, L. Alexander, C. Kelly, et al. Journal of Thoracic Oncology 2021;16(10):1705-1717. PubMed · Publisher · Free full text
• A comparison between MRI and CT in the assessment of primary tumour volume in mesothelioma. S. Tsim, G.W. Cowell, A. Kidd, et al. Lung Cancer 2020;150:12-20. PubMed · Publisher
• Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. Y. Ohara, A. Enomoto, Y. Tsuyuki, et al. Oncology Reports 2020;44(3):838-848. PubMed · Publisher · Free full text
• COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. M.C. Garassino, J.G. Whisenant, L.C. Huang, et al. The Lancet. Oncology 2020;21(7):914-922. PubMed · Publisher · Free full text
• Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors. C. Shao, G. Li, L. Huang, et al. JAMA Network Open 2020;3(10):e2025109. PubMed · Publisher · Free full text
• Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study. A. Trama, C. Proto, D. Signorelli, et al. Thoracic Cancer 2020;11(6):1661-1669. PubMed · Publisher · Free full text
• Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study. L. de Vos, M. Jung, R.M. Koerber, et al. The Journal of Molecular Diagnostics 2020;22(7):920-933. PubMed · Publisher
• Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma. D. Horio, T. Minami, H. Kitai, et al. Cancer Science 2020;111(8):2895-2906. PubMed · Publisher · Free full text

2010s

• A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma. A. Minchom, D. Mak, R. Gunapala, et al. PloS One 2019;14(11):e0225509. PubMed · Publisher · Free full text
• Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust. V. Casillo, S. Cerri, A. Ciervo, et al. BMC Pulmonary Medicine 2019;19(1):170. PubMed · Publisher · Free full text
• Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy. D. Halpenny, M. Raj, A. Rimner, et al. European Radiology 2019;29(7):3696-3704. PubMed · Publisher · Free full text
• Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study. S. Shoji, M. Hosojima, H. Kabasawa, et al. BMC Cancer 2019;19(1):1170. PubMed · Publisher · Free full text
• Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark. V. Panou, M. Vyberg, C. Meristoudis, et al. Scandinavian Journal of Work, Environment & Health 2019;45(1):82-89. PubMed · Publisher
• The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients. A.C. Bibby, P. Halford, D. De Fonseka, et al. Annals of the American Thoracic Society 2019;16(10):1273-1279. PubMed · Publisher
• Investigating unilateral pleural effusions: the role of cytology. D.T. Arnold, D. De Fonseka, S. Perry, et al. The European Respiratory Journal 2018;52(5). PubMed · Publisher
• Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study. C. Olivier, J.M. Grosbois, A.B. Cortot, et al. BMC Cancer 2018;18(1):178. PubMed · Publisher · Free full text
• Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience. J. Leemans, C. Dooms, V. Ninane, et al. Respirology 2018;23(6):613-617. PubMed · Publisher
• Association between lung cancer somatic mutations and occupational exposure in never-smokers. C. Paris, P. Do, B. Mastroianni, et al. The European Respiratory Journal 2017;50(4). PubMed · Publisher
• Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study. A.C. Bibby, D. De Fonseka, A.J. Morley, et al. BMC Palliative Care 2017;16(1):71. PubMed · Publisher · Free full text
• Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study. S. Valmary-Degano, P. Colpart, L. Villeneuve, et al. European Journal of Surgical Oncology 2017;43(10):1915-1923. PubMed · Publisher
• Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. S. Herrera Lara, E. Fernández-Fabrellas, G. Juan Samper, et al. Lung 2017;195(5):653-660. PubMed · Publisher
• The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. S. Tsim, D.B. Stobo, L. Alexander, et al. Lung Cancer 2017;103:38-43. PubMed · Publisher · Free full text
• Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases. M.J. Cruz, V. Curull, L. Pijuan, et al. Archivos de Bronconeumología 2017;53(6):318-323. In English, Spanish. PubMed · Publisher
• Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study. S. Tsim, C. Kelly, L. Alexander, et al. BMJ Open 2016;6(11):e013324. PubMed · Publisher · Free full text
• The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. M. Konecny, J. Markus, I. Waczulikova, et al. Neoplasma 2016;63(2):246-53. PubMed · Publisher
• Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study. R. Thomas, F. Piccolo, D. Miller, et al. Chest 2015;148(3):746-751. PubMed · Publisher
• Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: an observational study. A. Hercbergs, R.E. Johnson, O. Ashur-Fabian, et al. The Oncologist 2015;20(1):72-6. PubMed · Publisher · Free full text
• Physical activity in people with asbestos related pleural disease and dust-related interstitial lung disease: An observational study. M.T. Dale, Z.J. McKeough, P.A. Munoz, et al. Chronic Respiratory Disease 2015;12(4):291-8. PubMed · Publisher
• Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion. E.T.H. Fysh, S. Bielsa, C.A. Budgeon, et al. Chest 2015;147(6):1629-1634. PubMed · Publisher
• Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). K. Odendahl, W. Solass, C. Demtröder, et al. European Journal of Surgical Oncology 2015;41(10):1379-85. PubMed · Publisher
• Screening of miners and millers at decreasing levels of asbestos exposure: comparison of chest radiography and thin-section computed tomography. M. Terra-Filho, E. Bagatin, L.E. Nery, et al. PloS One 2015;10(3):e0118585. PubMed · Publisher · Free full text
• The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial. D.T. Arnold, C.E. Hooper, A. Morley, et al. British Journal of Cancer 2015;112(7):1183-9. PubMed · Publisher · Free full text
• The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication. C.E. Hooper, I.D. Lyburn, J. Searle, et al. British Journal of Cancer 2015;112(7):1175-82. PubMed · Publisher · Free full text
• Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature. K. Stamou, D. Tsamis, N. Pallas, et al. International Journal of Hyperthermia 2015;31(8):850-6. PubMed · Publisher
• Comparison of the ultra-low-dose Veo algorithm with the gold standard filtered back projection for detecting pulmonary asbestos-related conditions: a clinical observational study. M. Tekath, F. Dutheil, R. Bellini, et al. BMJ Open 2014;4(5):e004980. PubMed · Publisher · Free full text
• Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A.P. Rodt, R.O. Svarrer, L.H. Iversen. World Journal of Surgical Oncology 2013;11:232. PubMed · Publisher · Free full text
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. L.H. Iversen, P.C. Rasmussen, R. Hagemann-Madsen, et al. Colorectal Disease 2013;15(7):e365-72. PubMed · Publisher

Browse every journal in the library or other types of article.